Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of TAH Tablet vs Co-administration in Healthy Males
NCT02739672Phase 1Completed
- Sponsor
- Ildong Pharmaceutical Co Ltd
- Start
- Jan 2016
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of telmisartan, amlodipine and hydrochlorothiazide in hypertension (HTN) (2 arms), sponsored by Ildong Pharmaceutical Co Ltd. Primary endpoints: Area Under the Concentration-Time Curve from Time Zero to Last Quantifiable Concentration at 144 hours and Maximum Plasma Concentration at 144 hours. Started Jan 2016; status: completed.
02
Drugs
telmisartanamlodipinehydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02739672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02739672.